Contact
searchSearch
HMP Global

Conference Coverage

CIO logo
CIO 2025
Current Status of Histotripsy: Liver, Renal, and Beyond
01/29/2026
Laura Simson, MA
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal...
01/29/2026
Vascular Disease Management
Interview
Radiation Therapy Alone vs Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation for Painful Spine Metastasis: A Phase 2 Randomized Controlled Trial
01/15/2026
Brian J. Schiro, MD
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his stud yon radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his stud yon radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the...
01/15/2026
Vascular Disease Management
CIO image
CIO 2025
Y90: Year in Review
11/12/2025
Laura Simson, MA
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J....
11/12/2025
Vascular Disease Management
RGandhi
CIO 2025
Y90 Dosimetry Pre-Conference Training for Interventional Oncology in Miami Beach
09/26/2025
Ripal Gandhi, MD
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium...
09/26/2025
Vascular Disease Management
BO_IP_headshots
SIO Conference Coverage
An Exciting Frontier: The Rise of Robotics in Interventional Oncology
01/29/2025
Bruno C. Odisio, MD, PhD, FSIR, FCIRSE; Iwan Paolucci, PhD
In advance of the 2025 SIO conference, Dr Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, spoke with VDM about their upcoming sessions on Robotics, Navigation, Guidance, and Confirmation.
In advance of the 2025 SIO conference, Dr Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, spoke with VDM about their upcoming sessions on Robotics, Navigation, Guidance, and Confirmation.
In advance of the 2025 SIO...
01/29/2025
Vascular Disease Management
AJ Gunn, MD, University of Alabama at Birmingham
Videos
Percutaneous Renal Ablation
10/17/2024
Andrew J. Gunn, MD
AJ Gunn, MD, discusses percutaneous renal ablation.
AJ Gunn, MD, discusses percutaneous renal ablation.
AJ Gunn, MD, discusses...
10/17/2024
Vascular Disease Management
Altan Ahmed, MD, Moffitt Cancer Center
Videos
Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
10/16/2024
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses...
10/16/2024
Vascular Disease Management
Nainesh Parikh, MD, Moffitt Cancer Center
Videos
Emerging Indications for Prostate Artery Embolization
10/16/2024
Nainesh Parikh
Nainesh Parikh, MD, discusses the emerging indications for prostate artery embolization among patients with prostate cancer.
Nainesh Parikh, MD, discusses the emerging indications for prostate artery embolization among patients with prostate cancer.
Nainesh Parikh, MD, discusses...
10/16/2024
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Cardiovascular Scientific Forum
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
02/03/2026
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.--Feb. 3, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on...
Physician-led Collaboration...
02/03/2026
Vascular Disease Management
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
Acquisitions
Boston Scientific Announces Agreement to Acquire Penumbra, Inc.
01/15/2026
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA,...
01/15/2026
Cath Lab Digest
Peripheral Arterial Disease
CIS and Terrebonne General Are First in Louisiana to Use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter
01/09/2026
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA – Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to use the AngioSafe Santreva™-ATK Endovascular Revascularization Catheter to...
JANUARY 8, 2026 –HOUMA, LA...
01/09/2026
Vascular Disease Management
Radiation Safety
Rampart Launches SECURE Clinical Program to Advance Clinical Evidence for Next Generation Radiation Protection
01/08/2026
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind,...
01/08/2026
Vascular Disease Management
Deep Venous Disease
Gore Gains FDA Approval for First Deep Venous Stent Indicated for the IVC and Iliofemoral Veins
01/06/2026
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz. (January 6, 2026) — W. L. Gore & Associates’...
The GORE® VIABAHN® FORTEGRA...
01/06/2026
Vascular Disease Management
Neuro Intervention
Penumbra Receives CE Mark for MIDWAY and ACCESS25 Delivery Catheters in Europe
12/19/2025
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery...
12/19/2025
Vascular Disease Management
Thrombectomy
Study Finds CAVT (Computer-Assisted Vacuum Thrombectomy) Shortens Hospital Stay and May Ease Burden on Hospital Systems
12/16/2025
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs. 
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs. 
The research suggests that CAVT,...
12/16/2025
Cath Lab Digest
Intravascular Imaging
Philips Agrees to Acquire SpectraWAVE Inc., Advancing Next-Generation Coronary Intravascular Imaging and Physiological Assessment With AI
12/16/2025
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled...
Acquisition of SpectraWAVE’s...
12/16/2025
Vascular Disease Management
Acute Type A Dissection
Gore Announces First Patient Implant of the GORE® Ascending Stent Graft for Treatment of Acute Type A Dissection in ARISE III Pivotal Study
12/15/2025
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant of an investigational endovascular stent graft for the treatment of acute Type A dissections marks a critical milestone.
The first pivotal trial implant...
12/15/2025
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use